Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Predicting success: optimizing phase II ALS trials for the transition to phase III.

Predicting success: optimizing phase II ALS trials for the transition to phase III. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar; 15(1-2):1-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.